SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Marwa Karol J.)
 

Search: WFRF:(Marwa Karol J.) > Lumefantrine plasma...

Lumefantrine plasma concentrations in uncontrolled conditions among patients treated with artemether-lumefantrine for uncomplicated plasmodium falciparum malaria in Mwanza, Tanzania

Marwa, Karol J. (author)
Catholic Univ Hlth & Allied Sci, Dept Pharmacol, Mwanza, Tanzania.
Liwa, Anthony C. (author)
Catholic Univ Hlth & Allied Sci, Dept Pharmacol, Mwanza, Tanzania.
Konje, Eveline (author)
Catholic Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Mwanza, Tanzania.
show more...
Mwita, Stanley (author)
Catholic Univ Hlth & Allied Sci, Sch Pharm, Mwanza, Tanzania.
Kamugisha, Erasmus (author)
Catholic Univ Hlth & Allied Sci, Dept Biochem, Mwanza, Tanzania.
Swedberg, Göte (author)
Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi
show less...
Catholic Univ Hlth & Allied Sci, Dept Pharmacol, Mwanza, Tanzania Catholic Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Mwanza, Tanzania. (creator_code:org_t)
Elsevier, 2022
2022
English.
In: International Journal of Infectious Diseases. - : Elsevier. - 1201-9712 .- 1878-3511. ; 123, s. 192-199
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: Therapeutic efficacy of artemether-lumefantrine is highly dependent on adequate systemic exposure to the partner drug lumefantrine particularly day 7 lumefantrine plasma concentration. There has been contradicting findings on the role of the cut-off values in predicting treatment outcomes among malaria patients in malaria endemic regions. This study assesses the day 3 and 7 lumefantrine plasma concentrations including related determinant factors and their influence on treatment outcomes among treated Tanzanian children and adults in uncontrolled conditions (real life condition).Methods: Data was nested from an efficacy study employing the WHO protocol, 2015 for monitoring antimalarial drug efficacy. Lumefantrine plasma concentration was measured by high performance liquid chromatography with ultraviolet (HPLC-UV).Results: Lumefantrine plasma concentrations below 175ng/ml and 20 0ng/ml on day 3 and 7 did not affect adequate clinical and parasitological response (ACPR) and recurrence of infection ( p = 0.428 and 0.239 respectively). Age and baseline parasitemia were not as-sociated to day 3 median lumefantrine plasma concentrations (p = 0.08 and 0.31 respectively) and day 7 lumefantrine plasma concentrations (p = 0.07 and 0.41 respectively). However, the day 3 and day 7 lumefantrine plasma concentrations were significantly higher in males compared to females ( p = 0.03 and 0.042 respectively).Conclusion: Lumefantrine plasma concentrations below cut-off points (175ng/ml and 20 0ng/ml) on day 3 and 7 did not influence treatment outcomes.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)

Keyword

Lumefantrine
day 7 concentration
day 3 concentration
treatment outcomes and Tanzania

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view